MG
SPRB

Marex Group’s Spruce Biosciences SPRB Stock Holding History

Marex Group’s Portfolio SPRB Stock Details SPRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-197
Closed -$4.29K – 979
2025
Q1 		$4.29K Hold
197
– – ﹤0.01% 678
2024
Q4 		$6.22K Hold
197
– – ﹤0.01% 665
2024
Q3 		$7.03K Hold
197
– – ﹤0.01% 592
2024
Q2 		$7.66K Buy
+197
New +$10.6K ﹤0.01% 623

Other funds holding SPRB

Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
CSC
Caldwell Sutter Capital Sausalito, California $246M AUM 23.62% 1-Year Est. Return

Marex Group's SPRB Position: Q2 2025 in Review

Marex Group sold out of Spruce Biosciences (SPRB) in Q2 2025, closing a stake of 197 shares — an estimated $4.29K sold.

Marex Group first reported a position in SPRB in Q2 2024 and held it in 4 quarters. The position peaked at $7.66K in Q2 2024. 3 funds tracked by Wall St. Rank hold SPRB as of Q2 2025.

  • Marex Group reported no remaining Spruce Biosciences position as of Q2 2025 after selling out during the quarter.
  • Marex Group sold 197 Spruce Biosciences shares in Q2 2025, an estimated $4.29K.
  • Marex Group first reported a position in Spruce Biosciences in Q2 2024 and held it in 4 quarters.
  • Marex Group's Spruce Biosciences position peaked at $7.66K in Q2 2024.
  • 3 funds tracked by Wall St. Rank held Spruce Biosciences as of Q2 2025.

Based on Marex Group's 13F filing for Q2 2025, filed 19 Aug 2025.